Evidence map›Paper›PMID 37915395›Full record

ArticleMolecular syndromology2023

Novel

Giulia Rosti, Silvia Boeri, Maria Teresa Divizia, Livia Pisciotta, Maria Margherita Mancardi, Margherita Lerone, Maria Cerminara, Martina Servetti, Giovanni Spirito, Diego Vozzi and 5 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Molecular syndromology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Giulia RostiDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Silvia BoeriDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Maria Teresa DiviziaMedical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Livia PisciottaChild Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milan, Italy.
Maria Margherita MancardiChild Neuropsychiatry Unit, ERN EpiCARE Centre, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Margherita LeroneMedical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Maria CerminaraDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Martina ServettiDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Giovanni SpiritoDepartment of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genoa, Italy.
Diego VozziDepartment of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genoa, Italy.
Marco FontanaMedical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Stefano GustincichDepartment of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genoa, Italy.
Lino NobiliDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Federico ZaraDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Aldamaria PulitiDipartimento di Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili (DINOGMI), Università di Genova, Genoa, Italy.
Istituto Giannina Gaslini · ITItalian Institute of Technology · ITASST Fatebenefratelli Sacco · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Nowadays, whole-exome sequencing (WES) analysis is an essential part in the diagnostic pathway of individuals with complex phenotypes when routine exams, such as array-CGH and gene panels, have proved inconclusive. However, data on the diagnostic rate of WES analysis in adult individuals, negative to first-tier tests, are lacking. This is because initiatives with the aim of diagnosing rare diseases focus mainly on pediatric unsolved cases. Case Presentation: We hereby present a 45-year-old woman with severe intellectual disability, previous psychomotor developmental delay, behavioral disorders, stereotypies, nonconvulsive epilepsy, and dysmorphisms. The proband first came to our attention when she was 4 years old (in 1982); since then, she has undergone several clinical and instrumental assessments, without reaching a genetic diagnosis. At last, through WES analysis, a novel de novo variant in Conclusion: The variant is predicted to be deleterious and is most probably the cause of the proband's phenotype. The perseverance of the clinicians and the family allowed us to reach a diagnosis in a woman with a more than 30-year history of clinical evaluations, instrumental assessments, and genetic tests. This diagnosis was of significant relevance in genetic counseling for family members and the proband herself.

Indexed as

Adult patientDysmorphic facial featuresEpilepsyNeurodevelopmental disorderRare disorderSYNGAP1Whole-exome sequencing

Identifiers

PMID37915395
PMCPMC10617251
OpenAlexW4387247353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.